Generation of oligodendroglial cells by direct lineage conversion

Nature Biotechnology

Volumn 31, Issue 5, 2013, Pages 434-439

  Yang, Nan ^a   Zuchero, J Bradley ^a   Ahlenius, Henrik ^a   Marro, Samuele ^a   Ng, Yi Han ^a   Vierbuchen, Thomas ^a   Hawkins, John S ^a   Geissler, Richard ^a   Barres, Ben A ^a   Wernig, Marius ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALTERNATIVE APPROACH; DISEASE MODELING; DORSAL ROOT GANGLION CELLS; GENE EXPRESSION SIGNATURES; OLIGODENDROCYTES; PLURIPOTENT STEM CELLS; REGENERATIVE MEDICINE; THERAPEUTIC STRATEGY;

CELL CULTURE; STEM CELLS; TRANSCRIPTION FACTORS;

MAMMALS;

MYELIN; OLIGODENDROCYTE TRANSCRIPTION FACTOR 2; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR SOX10; TRANSCRIPTION FACTOR ZFP536; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL LINEAGE; COCULTURE; CONTROLLED STUDY; NERVE CELL DIFFERENTIATION; NERVE FIBER; NONHUMAN; OLIGODENDROCYTE PRECURSOR CELL; OLIGODENDROGLIA; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; RAT; SPINAL GANGLION; STEM CELL; STEM CELL TRANSPLANTATION;

ANIMALS; CELL DIFFERENTIATION; FIBROBLASTS; GENETIC ENHANCEMENT; MICE; MYELIN SHEATH; OLIGODENDROGLIA; STEM CELL TRANSPLANTATION; STEM CELLS; TRANSCRIPTION FACTORS;

EID: 84877329018     PISSN: 10870156     EISSN: 15461696     Source Type: Journal    
DOI: 10.1038/nbt.2564     Document Type: Article

References (39)

1. Potter, G.B., Rowitch, D.H. & Petryniak, M.A. Myelin restoration: progress and prospects for human cell replacement therapies. Arch. Immunol. Ther. Exp. (Warsz.) 59, 179-193 (2011).
2. Franklin, R.J. & Ffrench-Constant, C. Remyelination in the CNS: from biology to therapy. Nat. Rev. Neurosci. 9, 839-855 (2008).
3. Goldman, S.A. Progenitor cell-based treatment of the pediatric myelin disorders. Arch. Neurol. 68, 848-856 (2011).
4. Cummings, B.J. et al. Human neural stem cells differentiate and promote locomotor recovery in spinal cord-injured mice. Proc. Natl. Acad. Sci. USA 102, 14069-14074 (2005).
5. Franklin, R.J. & Ffrench-Constant, C. Stem cell treatments and multiple sclerosis. Br. Med. J. 340, c1387 (2010).
6. Brustle, O. et al. Embryonic stem cell-derived glial precursors: a source of myelinating transplants. Science 285, 754-756 (1999).
7. Learish, R.D., Brustle, O., Zhang, S.C. & Duncan, I.D. Intraventricular transplantation of oligodendrocyte progenitors into a fetal myelin mutant results in widespread formation of myelin. Ann. Neurol. 46, 716-722 (1999).
8. Sim, F.J. et al. CD140a identifes a population of highly myelinogenic, migration-competent and effciently engrafting human oligodendrocyte progenitor cells. Nat. Biotechnol. 29, 934-941 (2011).
9. Windrem, M.S. et al. Fetal and adult human oligodendrocyte progenitor cell isolates myelinate the congenitally dysmyelinated brain. Nat. Med. 10, 93-97 (2004).
10. Windrem, M.S. et al. Neonatal chimerization with human glial progenitor cells can both remyelinate and rescue the otherwise lethally hypomyelinated shiverer mouse. Cell Stem Cell 2, 553-565 (2008).
11. Wang, S. et al. Human iPSC-derived oligodendrocyte progenitor cells can myelinate and rescue a mouse model of congenital hypomyelination. Cell Stem Cell 12, 252-264 (2013).
12. Keirstead, H.S. et al. Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants remyelinate and restore locomotion after spinal cord injury. J. Neurosci. 25, 4694-4705 (2005).
13. Najm, F.J. et al. Rapid and robust generation of functional oligodendrocyte progenitor cells from epiblast stem cells. Nat. Methods 8, 957-962 (2011).
14. Vierbuchen, T. et al. Direct conversion of fbroblasts to functional neurons by defned factors. Nature 463, 1035-1041 (2010).
15. Pang, Z.P. et al. Induction of human neuronal cells by defned transcription factors. Nature 476, 220-223 (2011).
16. Caiazzo, M. et al. Direct generation of functional dopaminergic neurons from mouse and human fbroblasts. Nature 476, 224-227 (2011).
17. Pfsterer, U. et al. Direct conversion of human fbroblasts to dopaminergic neurons. Proc. Natl. Acad. Sci. USA 108, 10343-10348 (2011).
18. Son, E.Y. et al. Conversion of mouse and human fbroblasts into functional spinal motor neurons. Cell Stem Cell 9, 205-218 (2011).
19. Kim, J. et al. Direct reprogramming of mouse fbroblasts to neural progenitors. Proc. Natl. Acad. Sci. USA 108, 7838-7843 (2011).
20. Lujan, E., Chanda, S., Ahlenius, H., Sudhof, T.C. & Wernig, M. Direct conversion of mouse fbroblasts to self-renewing, tripotent neural precursor cells. Proc. Natl. Acad. Sci. USA 109, 2527-2532 (2012).
21. Thier, M. et al. Direct conversion of fbroblasts into stably expandable neural stem cells. Cell Stem Cell 10, 473-479 (2012).
22. Han, D.W. et al. Direct reprogramming of fbroblasts into neural stem cells by defned factors. Cell Stem Cell 10, 465-472 (2012).
23. Matsui, T. et al. Neural stem cells directly differentiated from partially reprogrammed fbroblasts rapidly acquire gliogenic competency. Stem Cells 30, 1109-1119 (2012).
24. Ring, K.L. et al. Direct reprogramming of mouse and human fbroblasts into multipotent neural stem cells with a single factor. Cell Stem Cell 11, 100-109 (2012).
25. Cahoy, J.D. et al. A transcriptome database for astrocytes, neurons, and oligodendrocytes: a new resource for understanding brain development and function. J. Neurosci. 28, 264-278 (2008).
26. Dugas, J.C., Tai, Y.C., Speed, T.P., Ngai, J. & Barres, B.A. Functional genomic analysis of oligodendrocyte differentiation. J. Neurosci. 26, 10967-10983 (2006).
27. Mallon, B.S., Shick, H.E., Kidd, G.J. & Macklin, W.B. Proteolipid promoter activity distinguishes two populations of NG2-positive cells throughout neonatal cortical development. J. Neurosci. 22, 876-885 (2002).
28. Barres, B.A. et al. Cell death and control of cell survival in the oligodendrocyte lineage. Cell 70, 31-46 (1992).
29. Chan, J.R. et al. NGF controls axonal receptivity to myelination by Schwann cells or oligodendrocytes. Neuron 43, 183-191 (2004).
30. Roach, A., Boylan, K., Horvath, S., Prusiner, S.B. & Hood, L.E. Characterization of cloned cDNA representing rat myelin basic protein: absence of expression in brain of shiverer mutant mice. Cell 34, 799-806 (1983).
31. Lazzarini, R.A. Myelin Biology and Disorders Vol. 2 (Academic Press, 2004).
32. Meissner, A., Wernig, M. & Jaenisch, R. Direct reprogramming of genetically unmodifed fbroblasts into pluripotent stem cells. Nat. Biotechnol. 25, 1177-1181 (2007).
33. Takahashi, K. & Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fbroblast cultures by defned factors. Cell 126, 663-676 (2006).
34. Wernig, M. et al. A drug-inducible transgenic system for direct reprogramming of multiple somatic cell types. Nat. Biotechnol. 26, 916-924 (2008).
35. Yu, J. et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 318, 1917-1920 (2007).
36. Takahashi, K. et al. Induction of pluripotent stem cells from adult human fbroblasts by defned factors. Cell 131, 861-872 (2007).
37. Yoo, A.S. et al. MicroRNA-mediated conversion of human fbroblasts to neurons. Nature 476, 228-231 (2011).
38. Eisen, M.B., Spellman, P.T., Brown, P.O. & Botstein, D. Cluster analysis and display of genome-wide expression patterns. Proc. Natl. Acad. Sci. USA 95, 14863-14868 (1998).
39. Chen, Y. et al. NS21: re-defned and modifed supplement B27 for neuronal cultures. J. Neurosci. Methods 171, 239-247 (2008).